Exousia Bio, Inc. (LMMY) › Cash & EquivalentsExousia Bio, Inc. (LMMY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2022: $10.1K2023: $7.9K$7.9K2022Cash & Equivalents (USD)2023Fiscal YearCash & EquivalentsChange YoY2023$7.9K-22.3%2022$10.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share